Fragile X - What is it?
 
 
Fragile X is the most common inherited cause of mental impairment and the most common known cause of autism.
Learn more about Fragile X

What is FRAXA?
 
 
FRAXA's mission is to accelerate progress toward effective treatments and a cure for Fragile X, by funding the most promising research. FRAXA has funded $17 million in research.
How close are we to a treatment?

Join FRAXA Mailing List
 
 






read latest newsletter here Best in America
What's New?
2/1/10: Roche has begun Phase 2 Fragile X Clinical Trial in the US

New Research Awards will be announced April 1st

2010 FRAXA Investigators Meeting is May 2-5th

11/2/09: Clinical Trial of STX107 (NIH)

9/18/09: Racing for a cure: Roche's Eureka Moment (Bloomberg)

FRAXA VIDEO and PHOTO contest winners

More News Releases


2009 FRAXA Annual Appeal progress
Thank you for supporting FRAXA's Annual Appeal
We've raised enough to fund 6 new research projects - still working toward the 7th!
©1997-2010 FRAXA Research Foundation, 45 Pleasant St., Newburyport, MA 01950. Tax ID: 04-3222167. Contact Us
Editor/writers: Katie Clapp, MS, and Michael Tranfaglia, MD. Updated 2/2/10. All rights reserved. Disclaimer Created by Dave Fullam and Icovia